Magnesium forms · Heretic

Short answer

Magnesium is required for over 600 enzymatic reactions and deficiency is widespread, but the salt form changes everything: glycinate and citrate absorb well, oxide barely does, and threonate is the only form with randomized-trial evidence for brain effects. Sleep trials are positive but modest; in one 155-person study 81% saw no clinically meaningful benefit, and meta-analyses show no lipid effect beyond a small HDL rise. A proven nutrient with real but modest trial effects.

Summary drafted from this entry’s sources; editorial review pending.

01Key questions

How do magnesium forms differ?

Substantially in absorption and targeting: glycinate and citrate absorb well, oxide poorly, and threonate is the only form with randomized-trial evidence for brain effects. Oxide absorbs so poorly its main use is as a laxative.

Does magnesium help you sleep?

Modestly. A 155-person RCT of bisglycinate improved insomnia scores versus placebo with a small effect size, and most participants got no clinically meaningful benefit; threonate sleep trials are similarly positive but small.²⁴

Does magnesium threonate improve cognition?

It is the only form with documented brain-magnesium elevation in animals and positive human RCTs for cognition and sleep, but effect sizes are modest and much of the trial pipeline is manufacturer-funded.²⁴¹⁰

Are most people magnesium deficient?

Many probably are. The body cites estimates of 70-80% with some deficiency and notes serum tests miss tissue depletion; PPIs, diuretics and alcohol deplete magnesium.⁸

Does magnesium lower cholesterol or blood pressure?

Not meaningfully for cholesterol; a 27-trial meta-analysis found only a small HDL increase after 12-plus weeks. The blood-pressure literature supports a modest effect.⁹

Magnesium is the most critical mineral most people are deficient in. Over 600 enzymatic reactions require it, including ATP production, DNA synthesis, and muscle/nerve function. However, the form matters enormously — bioavailability varies 5-10x between forms, and different forms serve different therapeutic purposes.

02The Deficiency Crisis

Why Deficiency Is Universal

Soil depletion: Modern agriculture has stripped magnesium from soils
Processed foods: Refined grains, sugars, and processed foods are magnesium-free
Medications: PPIs, diuretics, antibiotics, and proton pump inhibitors deplete magnesium
Stress: Both physical and psychological stress increase magnesium excretion
Alcohol: Regular alcohol consumption significantly depletes magnesium
Aging: Renal function declines; absorption decreases

Prevalence

Actual deficiency (including tissue deficiency) may be 70-80% of population
Standard serum blood tests miss 99% of deficiencies (only measures serum, not tissue magnesium)

03Magnesium Forms Compared

Quick Reference Table

Form	Bioavailability	Best For	Key Notes
Glycinate	High	Sleep, anxiety, relaxation	Most calming; glycine enhances sleep
Citrate	High (~90%)	General supplementation, constipation	Good absorption, mild laxative effect
Malate	High	Energy, fibromyalgia, muscle pain	Malic acid supports ATP production
Threonate	Moderate-High	Cognitive function, brain health	Crosses blood-brain barrier
Bisglycinate	Very High	Gentle on stomach, bioavailability	Chelated, no laxative effect
Taurate	High	Cardiovascular, calming	Taurine + magnesium
Orotate	Moderate	Heart health, performance	Supports DNA/RNA synthesis
Sulfate	Variable	Topical, Epsom salts	Poor oral absorption
Oxide	Low (~4%)	Laxative only	Avoid for supplementation
Chloride	Moderate	Stomach acid support	Good for digestion issues

Swipe table →

Detailed Form Analysis

Magnesium Glycinate

Absorption: Excellent (glycine is a small amino acid that enhances absorption)
Mechanism: Glycine is an inhibitory neurotransmitter; promotes calmness
Best applications:
Anxiety reduction
Muscle relaxation
Restless leg syndrome
Note: Most bioavailable oral form; least likely to cause diarrhea

Magnesium Citrate

Absorption: Very good (~90% in studies)
Mechanism: Citrate is an organic acid, readily absorbed
Best applications:
General supplementation
Constipation relief (osmotic laxative effect)
Kidney stone prevention (citrate binds calcium)
Note: Good default choice; may cause loose stools in some

Magnesium Malate

Absorption: High
Mechanism: Malic acid is a key player in Krebs cycle / ATP production
Best applications:
Chronic fatigue
Fibromyalgia
Muscle pain/soreness
Athletic performance

Magnesium Threonate (L-Threonate)

Absorption: Moderate-high
Mechanism: Specifically designed to cross blood-brain barrier
Best applications:
Cognitive function
Memory improvement
Neuroprotection
Brain fog
Note: Newer form; more expensive but promising for brain health

Magnesium Bisglycinate

Absorption: Very high; gentle on GI
Mechanism: Double-chelated form; glycine on both sides
Best applications:
Sensitive stomach
People who get diarrhea from other forms
General supplementation
Note: Best for long-term daily use

Magnesium Taurate

Absorption: High
Mechanism: Taurine supports heart function; both are calming
Best applications:
Cardiovascular health
Blood pressure support
Arrhythmia prevention
Anxiety with heart palpitations
Note: Excellent for stress + heart support

Magnesium Orotate

Absorption: Moderate
Mechanism: Orotic acid supports DNA/RNA synthesis
Best applications:
Athletic performance
Heart failure (historically used)
Recovery from exercise
Note: Less common; orotic acid has some cardiovascular research

Magnesium Oxide — AVOID

Absorption: Very poor (~4%)
Mechanism: Inorganic salt; poorly absorbed
Best applications: Only as osmotic laxative (Milk of Magnesia)
Note: Cheap but nearly useless as supplement

04Testing Methods

Method	What It Measures	Limitations
Serum magnesium	Blood levels only	Misses 99% of deficiencies (body maintains serum at expense of tissue)
RBC magnesium	Intracellular levels	Better than serum; still not perfect
EXA (Exactech) test	Tissue magnesium	Dried blood spot; measures tissue levels
Sublingual epithelial test	Tissue levels	More accurate for tissue deficiency
Urinary magnesium	Excretion levels	Useful for determining if supplementing is helping

Swipe table →

Recommendation: Don't rely on serum magnesium. Use RBC magnesium or EXA test for accurate assessment.

05Doses in studies

Uses

Form: Glycinate or bisglycinate
Timing: Evening (supports sleep; magnesium helps activate parasympathetic nervous system)
Duration: Ongoing/long-term

Doses in studies

Form: Glycinate
Stack: Can combine with glycine (3g), apigenin (50mg), or magnesium threonate
Note: Start lower; increase as needed

Doses in studies

Form: Glycinate or taurate
Stack: Can combine with L-theanine (200-400mg)
Note: Higher doses may be needed during acute stress

Athletic Performance / Muscle Recovery

Form: Malate or citrate
Note: Athletes need 10-20% more magnesium due to losses in sweat

Fibromyalgia / Chronic Pain

Form: Malate
Duration: May take 4-6 weeks for full effect
Evidence: Small but promising studies (e.g., Abraham & Myers 1995)

Cognitive Enhancement

Form: Threonate
Note: Take in morning; threonate may be stimulating for some

Cardiovascular Support

Form: Taurate or citrate
Stack: Consider with CoQ10 (100-200 mg) for synergistic effect

06Recent RCT Evidence (2024–2026) — Form-Specific Updates

The 2024–2026 literature has narrowed in on whether specific forms beat inexpensive generic salts. Several trials are large, registered, and placebo-controlled, allowing an honest read on effect sizes.

Magnesium L-Threonate (MgT, Magtein®) — Sleep and Cognition

Hausenblas et al. 2024 — Sleep RCT (PMC11381753, PMID 39252819, Sleep Med X): 80 adults aged 35–55 with self-reported sleep problems, randomized to 1 g/day MgT (≈ 75 mg elemental Mg) vs placebo for 21 days. ISI, LSEQ, and Restorative Sleep Questionnaire all improved significantly; Oura-ring-derived objective sleep was mixed (placebo declined on some metrics). Mood and daytime functioning improved. Funded by AIDP (Magtein manufacturer) — interpret accordingly.
Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC11381753
Lopresti & Smith 2026 — Cognitive + sleep RCT (Front Nutr 12:1729164, PMC12832366, PMID 41601871): Adult RCT of Magtein® measuring NIH Toolbox cognitive battery. Improved composite cognitive ability in older adults with anxiety, poor sleep, and self-reported memory complaints — but the composite was author-derived, not a validated global cognition measure. Secondary sleep outcomes also favoured MgT.
Source: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1729164/full
2026 Athletic-Performance RCT (NCT07015047): Collegiate-athlete trial evaluating MgT on sleep architecture, autonomic recovery, and cognitive function (in progress).
Honest read: Effect sizes for MgT are real but modest. It is the only well-studied oral form with documented brain-magnesium elevations in animals (Slutsky 2010) and reproducible cognitive/sleep effects in human RCTs. It is not a panacea.

Magnesium Bisglycinate — Sleep RCT

Schuster et al. 2025 — Bisglycinate Sleep RCT (Nature and Science of Sleep 17:2027–2040, PMC12412596): 155 adults reporting poor sleep, randomized to 250 mg elemental Mg as bisglycinate vs placebo for 4 weeks. ISI improved significantly vs placebo; effect was small (d ≈ 0.2) and ~81% of participants did not achieve a clinically meaningful benefit. Benefit was concentrated in low-dietary-Mg participants.
Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC12412596
Hausenblas re-analysis 2024 caveat: Objective Oura data in the Hausenblas MgT trial showed the placebo group worsened over time rather than MgT dramatically improving — this is a common critique across recent Mg trials: small subjective gains, weak objective signals.

Magnesium and Cognitive Health — Systematic Review (2024)

Liu et al. 2024 — Meta-analysis of Mg and cognition (Adv Nutr 15(8):100272): Systematic review and meta-analysis covering RCTs and cohort studies on Mg forms, supplements, dietary intake, and biomarkers against cognitive outcomes. Reinforces an inverse association between higher Mg status and cognitive decline risk; effect sizes remain modest for oral supplements.
Source: https://www.sciencedirect.com/science/article/pii/S2161831324001066

Magnesium and Cardiovascular Disease — Updated Reviews (2024)

Source: https://www.mdpi.com/2072-6643/16/23/4223
Hariri et al. 2025 — Lipid-profile meta-analysis (Nutr J 24:24): Updated systematic review and dose-response meta-analysis of RCTs (27 trials; doses 20–548 mg/day; 4–24 weeks; populations: diabetic, MetS, PCOS, NAFLD, obese/overweight, healthy, hemodialysis, coronary disease, hypertension). Primary pooled estimates:
TC (21 studies, 24 datasets): MD +0.34 mg/dL (95% CI −1.75 to +2.43) — no effect.
TG (23 studies, 26 datasets): no effect.
LDL-C (20 studies, 24 datasets): no effect.
HDL-C (25 studies, 29 datasets): MD +1.24 mg/dL (significant) — small but consistent HDL-C increase.
Key subgroup signals: HDL-C benefit emerges only in studies ≥84 days; normomagnesemic participants show blunted response (renal homeostasis limits uptake); chloride and organic-acid salts drive most positive signals; inorganic oxide trials (Mortazavi hemodialysis, Razzaghi diabetic foot) account for some TC/LDL-C reductions. No dose-response on absolute mg/day.
Mechanistic anchor: ↑ LCAT activity (raises HDL-C); ↑ desaturase activity → ↑ EPA/DHA from linoleic acid (also HDL-C); ↓ HMG-CoA reductase; improved insulin signaling.
Source: https://link.springer.com/article/10.1186/s12937-025-01085-w (DOI 10.1186/s12937-025-01085-w; PDF archived at Sources/Papers/doi_10.1186_s12937-025-01085-w.pdf)
Honest read: Magnesium supplementation is not an effective lipid-lowering intervention in the general adult population. The clinically meaningful signal is a small HDL-C increase after ≥12 weeks, particularly in deficient subjects on bioavailable salts. Do not market magnesium as a "cholesterol fix."

Magnesium and Malate — Fibromyalgia

The malate/fibromyalgia evidence base remains weak. Boulis et al. 2021 literature review found mainly negative correlation studies and small intervention trials. A 2024 rat-model study (Xu et al., J Nanobiotechnology 22:368) showed magnesium malate–modified calcium phosphate bone cement enhanced bone repair but is non-supplemental; not applicable to oral malate dosing for fibromyalgia. No 2024–2026 placebo-controlled RCT has validated oral malate for fibromyalgia pain endpoints. The 1995 Abraham & Myers protocol remains the canonical clinical reference; benefit appears to require 4–6 weeks minimum and may be limited to a subgroup with measurable deficiency.

Bottom Line on Form Choice

Recent evidence does not overturn the older hierarchy (avoid oxide; glycinate/bisglycinate/citrate are cheap workhorses; threonate is the only well-evidenced brain-targeted form; malate's fibromyalgia edge is anecdote-strength). What 2024–2026 data add:

Bisglycinate sleep effects are real but small — do not present as a "cure" for insomnia.
Threonate has the best-funded cognitive/sleep RCT pipeline but modest effect sizes and manufacturer funding bias.
Magnesium status (dietary + serum) matters more than the specific salt for cardiovascular and mortality endpoints.

07Drug Interactions

Medication	Interaction
Proton pump inhibitors (PPIs)	Severely reduce magnesium absorption; long-term use causes deficiency
Diuretics	Increase magnesium excretion
Antibiotics (tetracyclines, quinolones)	Magnesium binds to them; take 2-4 hours apart
Bisphosphonates	Magnesium reduces absorption; take 2 hours apart
ACE inhibitors	May increase magnesium levels; monitor
Digoxin	Magnesium enhances effect; may need lower dose

Swipe table →

What studies and practitioners report

Amounts as reported in the cited sources: trial doses with the population studied, and practitioner-reported ranges marked as such. Not medical advice.

Trial 500 mg/day · Magnesium older adults with primary insomnia, n=46 PMID 23853635

08Connections

Neighborhood · 8 linked entriesOpen full map →

09Sources

PMC11381753PMC11381753
PubMed 39252819PubMed 39252819
PMC12832366PMC12832366
PubMed 41601871PubMed 41601871
NCT07015047NCT07015047
PMC12412596PMC12412596
DOI 10.1186/s12937-025-01085-wDOI 10.1186/s12937-025-01085-w
PubMed 28588366PubMed 28588366
PubMed 28655598PubMed 28655598
PubMed 20152124PubMed 20152124
PMC12535714PMC12535714

10Entry history

14 Oct 2026